English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Select site language

Ecansya (Capecitabine Krka) (capecitabine) – Conditions or restrictions regarding supply and use - L01BC06

Updated on site: 06-Oct-2017

Medication nameEcansya (Capecitabine Krka)
ATC CodeL01BC06
Substancecapecitabine
ManufacturerKrka, d.d., Novo mesto

A.MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturers responsible for batch release Accord Healthcare Ltd.

Ground Floor

Sage House 319 Pinner road

North Harrow, Middx HA1 4HF United Kingdom

Pharmacare Premium Ltd

HHF 003, Hal Far Industrial Estate Birzebbugia, BBG 3000

Malta

KRKA, d.d., Novo mesto Šmarješka cesta 6

8501 Novo mesto Slovenia

The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).

C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION

Periodic Safety Update Reports

The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.

D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT

Risk Management Plan (RMP)

Not applicable.

Comments

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Help
  • Get it on Google Play
  • About
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    prescription drugs listed